Bone regeneration by human dental pulp stem cells using a helioxanthin derivative and cell-sheet technology

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Biomaterials Science

Background:

• Human dental pulp stem cells (DPSCs) possess multipotent differentiation capabilities and superior clonogenic/proliferative potential compared to bone marrow stem cells (BMSCs).
• Severe bone defects present significant clinical challenges, necessitating innovative bone regenerative strategies.
• 4-(4-methoxyphenyl)pyrido[40,30:4,5]thieno[2,3-b]pyridine-2-carboxamide (TH), a helioxanthine derivative, has shown potential in inducing osteogenesis in preclinical models.

Purpose of the Study:

• To investigate the efficacy of TH in inducing osteogenic differentiation of human DPSCs.
• To evaluate the in vivo bone regenerative capacity of TH-treated DPSCs using a cell-sheet transplantation system.

Main Methods:

• DPSCs were isolated from human wisdom teeth and cultured in osteogenic or regular media with or without TH.
• Osteogenic differentiation was assessed by comparing TH-treated DPSCs to controls and bone morphogenetic protein-2 (BMP-2) treated cells.
• In vivo osteogenesis was evaluated by transplanting DPSC sheets into mouse calvarial defects.

Main Results:

• TH significantly enhanced osteogenic differentiation of DPSCs in osteogenic medium, outperforming BMP-2.
• TH induced osteogenesis in both DPSCs and BMSCs, though with distinct gene expression profiles.
• Successful bone regeneration was achieved in vivo using scaffold-free DPSC sheets treated with TH.

Conclusions:

• TH-treated DPSCs represent a promising cell source for bone regenerative medicine.
• Scaffold-free transplantation of TH-treated DPSC sheets offers a convenient and effective method for bone healing.